HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+7.61%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$175M
AUM Growth
+$175M
(+5.7%)
Cap. Flow
+$6.43M
Cap. Flow
% of AUM
3.67%
Top 10 Holdings %
Top 10 Hldgs %
36.64%
Holding
129
New
19
Increased
30
Reduced
20
Closed
16
Top Buys
| 1 |
NLSN
Nielsen Holdings plc
NLSN
|
$3.17M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
$2.73M |
| 3 |
VMW
VMware, Inc
VMW
|
$2.51M |
| 4 |
Repare Therapeutics
RPTX
|
$1.84M |
| 5 |
Cogent Biosciences
COGT
|
$1.78M |
Top Sells
| 1 |
COHR
Coherent Inc
COHR
|
$3.62M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$2.96M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$2.37M |
| 4 |
IDEAYA Biosciences
IDYA
|
$1.8M |
| 5 |
Dyne Therapeutics
DYN
|
$1.77M |
Sector Composition
| 1 | Healthcare | 46.35% |
| 2 | Technology | 22.42% |
| 3 | Financials | 15.33% |
| 4 | Communication Services | 4.08% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
BioMarin Pharmaceuticals
BMRN
$11.2B
| $833K | 0.48% | 9,821 +1,225 | +14% | +$104K |
|
52
Revolution Medicines
RVMD
$7.1B
| $829K | 0.47% | 42,056 +21,371 | +103% | +$421K |
|
53
argenx
ARGX
$43.6B
| $818K | 0.47% | 2,318 +165 | +8% | +$58.2K |
|
54
Xenon Pharmaceuticals
XENE
$2.98B
| $815K | 0.47% | 22,572 +137 | +0.6% | +$4.95K |
|
55
Arvinas
ARVN
$568M
| $812K | 0.46% | 18,256 +2,570 | +16% | +$114K |
|
|
BLU
56
DELISTED
BELLUS Health Inc.
BLU
| $811K | 0.46% | 76,844 +40,480 | +111% | +$427K |
|
57
United Therapeutics
UTHR
$13.8B
| $809K | 0.46% | 3,866 +414 | +12% | +$86.6K |
|
|
HZNP
58
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $808K | 0.46% | 13,055 +5,636 | +76% | +$349K |
|
59
Regenxbio
RGNX
$451M
| $785K | 0.45% | 29,696 +13,344 | +82% | +$353K |
|
60
Immunocore
IMCR
$1.62B
| $779K | 0.44% | +16,588 | New | +$779K |
|
|
SGEN
61
DELISTED
Seagen Inc. Common Stock
SGEN
| $777K | 0.44% | +5,678 | New | +$777K |
|
|
MRTX
62
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $755K | 0.43% | 10,811 -285 | -3% | -$19.9K |
|
63
Axsome Therapeutics
AXSM
$6.05B
| $753K | 0.43% | +16,886 | New | +$753K |
|
64
Galapagos
GLPG
$2.07B
| $746K | 0.43% | 17,499 +5,698 | +48% | +$243K |
|
65
Merus
MRUS
$4.98B
| $741K | 0.42% | 36,994 -3,487 | -9% | -$69.8K |
|
|
TCDA
66
DELISTED
Tricida, Inc. Common Stock
TCDA
| $733K | 0.42% | 69,970 +1,422 | +2% | +$14.9K |
|
67
Amicus Therapeutics
FOLD
$2.34B
| $719K | 0.41% | 68,830 -21,404 | -24% | -$224K |
|
68
Alphabet (Google) Class C
GOOG
$2.58T
| $718K | 0.41% | 7,472 +7,176 | +2,424% | +$690K |
|
69
Celldex Therapeutics
CLDX
$1.47B
| $715K | 0.41% | 25,426 +3,014 | +13% | +$84.8K |
|
70
Iovance Biotherapeutics
IOVA
$807M
| $691K | 0.39% | 72,104 +27,142 | +60% | +$260K |
|
|
CERE
71
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $667K | 0.38% | 23,611 -4,839 | -17% | -$137K |
|
72
GH Research
GHRS
$837M
| $660K | 0.38% | 56,769 -7,167 | -11% | -$83.3K |
|
73
Design Therapeutics
DSGN
$315M
| $638K | 0.36% | +38,152 | New | +$638K |
|
74
Madrigal Pharmaceuticals
MDGL
$9.76B
| $619K | 0.35% | 9,527 +4,727 | +98% | +$307K |
|
|
ISEE
75
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $611K | 0.35% | 34,060 -23,859 | -41% | -$428K |
|